Rise Advisors’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-30
Closed -$2.92K 635
2023
Q3
$2.92K Hold
30
﹤0.01% 424
2023
Q2
$3.26K Hold
30
﹤0.01% 461
2023
Q1
$3.23K Hold
30
﹤0.01% 511
2022
Q4
$3.27K Hold
30
﹤0.01% 499
2022
Q3
$3K Hold
30
﹤0.01% 496
2022
Q2
$3K Hold
30
﹤0.01% 503
2022
Q1
$3K Hold
30
﹤0.01% 483
2021
Q4
$3.73K Buy
+30
New +$3.59K ﹤0.01% 446

Other funds holding FXH

Rise Advisors's FXH Position: Q4 2023 in Review

Rise Advisors sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q4 2023, closing a stake of 30 shares — an estimated $2.92K sold.

Rise Advisors first reported a position in FXH in Q4 2021 and held it in 8 quarters. The position peaked at $3.73K in Q4 2021. 262 funds tracked by Wall St. Rank hold FXH as of Q4 2023.

  • Rise Advisors reported no remaining First Trust Health Care AlphaDEX Fund position as of Q4 2023 after selling out during the quarter.
  • Rise Advisors sold 30 First Trust Health Care AlphaDEX Fund shares in Q4 2023, an estimated $2.92K.
  • Rise Advisors first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2021 and held it in 8 quarters.
  • Rise Advisors's First Trust Health Care AlphaDEX Fund position peaked at $3.73K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q4 2023.

Based on Rise Advisors's 13F filing for Q4 2023, filed 10 Jan 2024.